Table 3.
Effects | MBM | Phy | AB | Gizzard + digesta | Liver | Fat pad | Breast | Ileum | Leg |
---|---|---|---|---|---|---|---|---|---|
2-way interactions | |||||||||
MBM*AB | |||||||||
− | − | 1.71a,b | 2.31 | 0.71 | 18.78 | 0.90 | 19.12 | ||
− | + | 1.82a | 2.30 | 0.71 | 19.40 | 0.76 | 20.22 | ||
+ | − | 1.87a | 2.29 | 0.62 | 17.10 | 0.80 | 20.40 | ||
+ | + | 1.58b | 2.25 | 0.73 | 18.42 | 0.70 | 20.31 | ||
Phy*AB | |||||||||
500 | − | 1.52b | 2.25 | 0.69 | 18.43 | 0.84 | 19.18 | ||
500 | + | 1.66b | 2.31 | 0.74 | 19.03 | 0.72 | 20.68 | ||
1,500 | − | 2.05a | 2.35 | 0.64 | 17.45 | 0.87 | 20.34 | ||
1,500 | + | 1.74a,b | 2.25 | 0.70 | 18.81 | 0.73 | 19.18 | ||
MBM | − | 1.77 | 2.31 | 0.71 | 19.09 | 0.83a | 19.67 | ||
+ | 1.72 | 2.27 | 0.68 | 17.77 | 0.74b | 20.36 | |||
AB | − | 1.77 | 2.30 | 0.67 | 17.94 | 0.85a | 19.76 | ||
+ | 1.70 | 2.28 | 0.72 | 18.92 | 0.73b | 20.27 | |||
P > f | |||||||||
MBM | 0.686 | 0.874 | 0.445 | 0.105 | 0.011 | 0.183 | |||
Phy | 0.006 | 0.812 | 0.443 | 0.489 | 0.588 | 0.655 | |||
AB | 0.462 | 0.694 | 0.241 | 0.234 | 0.001 | 0.296 | |||
MBM × Phy | 0.999 | 0.805 | 0.465 | 0.820 | 0.525 | 0.224 | |||
MBM × AB | 0.043 | 0.909 | 0.268 | 0.717 | 0.683 | 0.241 | |||
Phy × AB | 0.033 | 0.346 | 0.964 | 0.759 | 0.732 | 0.066 | |||
MBM × Phy × AB | 0.893 | 0.276 | 0.371 | 0.756 | 0.938 | 0.373 |
a,b,c Means in the same column within the main effect, 2-way interaction, or treatment means with different superscripts are different (P < 0.05).
2- or 3-way interaction separated by Tukey.
Abbreviations: AB, antibiotics; AB, salinomycin 60 ppm in S, G, F; Zn bacitracin 100 ppm in S, G and 50 ppm in F; MBM, meat and bone meal; Phy, phytase (Quantum Blue 5G).